Workflow
卫宁健康董事靳茂拟减持不超188万股,占总股本0.0854%

Core Viewpoint - The announcement reveals that the company's director and senior executive, Jin Mao, plans to reduce his shareholding in Weining Health Technology Group Co., Ltd. due to personal financial needs [1]. Group 1: Shareholding Details - Jin Mao currently holds 7.532336 million shares, representing 0.3423% of the company's total share capital [1]. - The planned reduction will occur within three months starting from November 4, 2025, to February 3, 2026, during which he will not sell shares in the designated window period [1]. - The maximum number of shares to be sold is 1.88 million, accounting for 0.0854% of the total share capital [1]. Group 2: Compliance and Commitments - Jin Mao's shares for reduction are sourced from pre-IPO shares, equity incentive shares, and shares acquired in the secondary market, including those from rights distributions [1]. - He has adhered to his commitment made during the IPO, which limits his annual transfer of shares to no more than 25% of his total holdings during his tenure and prohibits any transfer within six months after leaving the company [1]. - As of the announcement date, there are no ongoing commitments or guarantees related to the planned share reduction, and he has not violated any commitments [1]. Group 3: Impact on Company Structure - The share reduction plan will not lead to any change in the company's control, governance structure, or operational impact [2]. - The company will continue to monitor the progress of this share reduction plan and fulfill its information disclosure obligations as required [2].